Wavelet Medical and Aegis Ventures Launch AI Fetal EEG Monitoring Platform
Wavelet Medical and Aegis Ventures have partnered to develop the first non-invasive AI-powered fetal EEG monitoring platform. The device aims to improve maternal-fetal outcomes by detecting fetal brain signals through sensors on an abdomen belt. This technology seeks to address the limitations of traditional fetal heart rate monitoring, which often leads to unnecessary interventions. The platform is currently being tested at multiple clinical sites, with promising early data. The partnership also secured $7 million in seed funding to support commercialization efforts. 
